Related Experiment Video
Updated: Oct 25, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Advances and highlights in allergic rhinitis.
Yuan Zhang1,2,3, Feng Lan2, Luo Zhang1,2,3
1Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China.
Allergic rhinitis (AR) is a growing global health issue. Recent advances focus on environmental risk factors, precise diagnosis, immunological mechanisms, and COVID-19-era treatments for AR.
Area of Science:
- Immunology
- Environmental Health
- Public Health
Background:
- Allergic rhinitis (AR) presents a significant and increasing global health, medical, and economic burden.
- Recent research highlights environmental exposures, climate change, and lifestyle as key risk factors for AR prevalence.
- The COVID-19 pandemic necessitates adaptations in managing AR patients.
Purpose of the Study:
- To review major discoveries in allergic rhinitis over the past two years.
- To explore risk factors, diagnostic strategies, immunological mechanisms, and therapies for AR.
- To identify future research perspectives in AR management.
Main Methods:
- Review of recent scientific literature on allergic rhinitis.
- Analysis of risk factors, diagnostic approaches, and immunological underpinnings of AR.
- Evaluation of current and future therapeutic strategies for AR, considering the COVID-19 context.
Main Results:
- Environmental exposures, climate change, and lifestyle are significant risk factors for AR.
- A new phenotype, dual AR, highlights the importance of local inflammation assessment for precise diagnosis.
- Combined local and traditional diagnostic methods may improve precision medicine approaches for AR.
- Management of AR during the COVID-19 pandemic requires traditional treatments alongside public health measures like social distancing and hygiene.
- Further research is needed to understand cell profile changes post-allergen immunotherapy (AIT) and to accurately evaluate its efficacy.
Conclusions:
- Understanding the exposome is crucial for developing better risk profiles and mitigating allergic diseases.
- Precision diagnosis, potentially incorporating local inflammation measurement, is key for advancing AR management.
- Adapting AR care during the COVID-19 pandemic requires integrating public health guidelines with established treatments.
- Continued research into the immunological mechanisms and efficacy evaluation of allergen immunotherapy is essential.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Allergic Reactions
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

